Frees Fund logo

Frees Fund

Asia, Beijing, China, Beijing

Description

Frees Fund (峰瑞资本) is a prominent venture capital firm based in Beijing, China, with a strategic focus on technology startups in both China and the United States. Established in 2015, the firm positions itself as a versatile investor, providing capital across early and growth stages, including seed, angel, Series A, and later-stage rounds. Their dual-market approach allows them to tap into innovation hubs in both Eastern and Western economies.

The firm's investment thesis spans a diverse range of high-growth sectors, primarily focusing on TMT (Technology, Media, and Telecommunications), healthcare, advanced manufacturing, and consumer technologies. Frees Fund has demonstrated a robust investment pace, having made over 260 investments since its inception. Their portfolio includes notable companies across various industries, reflecting their broad yet targeted approach to identifying disruptive technologies and business models.

Frees Fund has successfully raised multiple funds, accumulating an impressive asset under management (AUM) exceeding $1.2 billion across 10 distinct funds. Their latest significant close was Frees Fund V in 2023, which secured $300 million, underscoring their continued ability to attract capital and commit to new ventures. The firm is known for its hands-on approach, often taking lead investor roles in its portfolio companies, and has achieved more than 10 successful exits, showcasing their capability to nurture startups from early development to successful market realization.

Frees Fund's typical first cheque sizes range significantly, reflecting their multi-stage investment strategy. For early-stage companies, initial investments generally fall within the range of $500,000 to $5 million. For more mature, growth-stage enterprises, the firm is prepared to deploy larger sums, with first cheques potentially reaching up to $20 million, enabling substantial scaling and market expansion. This flexible investment approach allows Frees Fund to support promising technology companies throughout their lifecycle.

Investor Profile

Frees Fund has backed more than 46 startups, with 16 new investments in the last 12 months alone. The firm has led 8 rounds, about 17% of its total and boasts 10 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Seed, Series B rounds (top funding stages).
  • Majority of deals are located in China, United States, Singapore.
  • Strong thematic focus on Artificial Intelligence (AI), E-Commerce, Software.
  • Led 5 rounds in the past year.
  • Typical check size: $500K – $20M.

Stage Focus

  • Series A (39%)
  • Seed (20%)
  • Series B (17%)
  • Angel (13%)
  • Series D (7%)
  • Convertible Note (2%)
  • Series C (2%)

Country Focus

  • China (70%)
  • United States (20%)
  • Singapore (7%)
  • Hong Kong (2%)

Industry Focus

  • Artificial Intelligence (Ai)
  • E-commerce
  • Software
  • Health Care
  • Manufacturing
  • Retail
  • Robotics
  • Biotechnology
  • Blockchain
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Frees Fund frequently co-invest with?

AI
North America, Massachusetts, United States, Boston
Co-Investments: 2
Shunwei Capital
Asia, Beijing, China, Beijing
Co-Investments: 3
IDG Capital
Asia, Beijing, China, Beijing
Co-Investments: 8
Chuxin Capital
Asia, Beijing, China, Beijing
Co-Investments: 2
BAI capital
Asia, Beijing, China, Beijing
Co-Investments: 2
FBG Capital
Asia, Central Region, Singapore, Singapore
Co-Investments: 2
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 3
Decent Capital
North America, California, United States, Palo Alto
Co-Investments: 2
Andreessen Horowitz
North America, California, United States, Menlo Park
Co-Investments: 2
Amino Capital
North America, California, United States, Palo Alto
Co-Investments: 2

Which angels does Frees Fund often collaborate with?

WG
North America, California, United States, San Francisco
Shared Deals: 1
MZ
North America, California, United States, Palo Alto
Shared Deals: 1
Shared Deals: 1
ML
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Frees Fund?

Yuanchuan Micro

Shanghai, Shanghai, China

Yuanchuan Micro specializes in system research and development, as well as sales of software and hardware equipment.

Information Technology
SeedJan 20, 2026
Oricell Therapeutics

Shanghai, Shanghai, China

OriCell Therapeutics aims to develop drugs with good efficacy and affordable prices for tumor immunotherapy.

Health CarePharmaceuticalProduct Research
Series CJan 12, 2026
Amount Raised: $70,000,000
Terminal brain technology

Shenzhen, Guangdong, China

Terminal Brain Technology is an AIGC distributed computing power network platform.

Artificial Intelligence (AI)Cloud ComputingInformation Technology
SeedJan 7, 2026
Ningkang Ruizhu

Zhuhai, Guangdong, China

Rezubio Pharmaceuticals is a targeted drugs developer.

BiotechnologyHealth Care
Series ADec 5, 2025
Amount Raised: $14,144,072

Baiyao Technology is a biopharmaceuticals company offering drug and treatment plan development utilizing AI simulation of life processes.

Artificial Intelligence (AI)Biopharma
AngelOct 24, 2025

Duochang Tech develops ultra-precision piezoelectric motion systems and extreme environment testing equipment.

AerospaceIndustrial AutomationRobotics
Series ASep 15, 2025
Mengyou Intelligence

Shijingshan, Beijing, China

Mengyou Intelligence provides smart interactive home robots.

Robotics
Series ASep 8, 2025
Dingou Biopharmaceuticals

Daxing, Beijing, China

Dingou Biotechnology is a developer of allergen diagnosis and treatment products.

BiopharmaBiotechnologyManufacturing
SeedMay 27, 2025
Boin Biotechnology

Zhangjiang, Shanghai, China

Boin Biotechnology is a cutting-edge biopharmaceutical

BiotechnologyPharmaceuticalTherapeutics
AngelMay 25, 2025
Interstellar Lightyear

Beijing, Beijing, China

Interstellar Lightyear Technology is a developer specializing in dexterous robotic hands.

Health CareIndustrial AutomationManufacturing
SeedMay 14, 2025

Find More Investors Like Frees Fund

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Frees Fund | Pipeseed